SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Precision BioSciences Q1 EPS $(0.520), Inline, Sales $7.000M Beat $4.260M Estimate

Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(0.520) per share which met the analyst consensus estimate. This is a 73.87 percent increase over losses of $(1.990) per share from the same period last

Benzinga · 05/15/2020 11:09

Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(0.520) per share which met the analyst consensus estimate. This is a 73.87 percent increase over losses of $(1.990) per share from the same period last year. The company reported quarterly sales of $7.000 million which beat the analyst consensus estimate of $4.260 million by 64.32 percent. This is a 28.16 percent increase over sales of $5.462 million the same period last year.